Showing results (201-210 of 239) with videos related to
Sort By:
Pageof 24
European Journal of Immunology|March 23, 2006
Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium diseaseAndrew P Fontenot, David M Edwards, Yuan K Chou, et al.Stroke|May 16, 2009
Recombinant T cell receptor ligand treats experimental strokeSandhya Subramanian, Bing Zhang, Yasuharu Kosaka, et al.Acta Psychiatrica Scandinavica|November 1, 1994
The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophreniaN Keks, J McGrath, T Lambert, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosisYuan K Chou, David M Edwards, Andrew D Weinberg, et al.European Journal of Immunology|April 12, 2013
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effectsGil Benedek, Roberto Meza-Romero, Shayne Andrew, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activationChunhe Wang, Jeffery L Mooney, Roberto Meza-Romero, et al.QJM : Monthly Journal of the Association of Physicians|March 12, 2005
Survival among hospital in-patients with troponin T elevation below levels defining myocardial infarctionG Cook, D Taylor, M France, et al.Plos One|February 25, 2017
Determining causes of genetic isolation in a large carnivore (Ursus americanus) population to direct contemporary conservation measuresAgnès Pelletier, Martyn E Obbard, Matthew Harnden, et al.Critical Reviews in Immunology|April 19, 2000
Human TCR as antigen: homologies and potentially cross-reactive HLA-DR2-restricted epitopes within the AV and BV CDR2 loopsA A Vandenbark, N Culbertson, T Finn, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic miceArthur A Vandenbark, Cathleen Rich, Jeff Mooney, et al.Pageof 24